<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Vis</journal-id><journal-id journal-id-type="publisher-id">MV</journal-id><journal-title>Molecular Vision</journal-title><issn pub-type="epub">1090-0535</issn><publisher><publisher-name>Molecular Vision</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">80</article-id><article-id pub-id-type="publisher-id">2008MOLVIS039</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Anti-chaperone &#x003b2;A3/A1<sub>102-117</sub> peptide interacting sites in human &#x003b1;B-crystallin</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Rao</surname><given-names>Guruprasad</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Santhoshkumar</surname><given-names>Puttur</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Sharma</surname><given-names>K. Krishna</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><aff id="aff1"><label>1</label>Department of Ophthalmology, University of Missouri-Columbia, Columbia, MO</aff><aff id="aff2"><label>2</label>Department of Biochemistry, University of Missouri-Columbia, Columbia, MO</aff></contrib-group><author-notes><corresp id="cor1">Correspondence to: K. Krishna Sharma, Ph.D., Department of Ophthalmology, University of Missouri-Columbia, 1 Hospital Drive, Columbia, MO, 65212; Phone: (573) 882-8478; FAX: (573) 884-4100; email: <ext-link ext-link-type="uri" xlink:href="mailto:sharmak@health.missouri.edu">sharmak@health.missouri.edu</ext-link></corresp></author-notes><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>26</day><month>3</month><year>2008</year></pub-date><volume>14</volume><fpage>666</fpage><lpage>674</lpage><history><date date-type="received"><day>31</day><month>1</month><year>2008</year></date><date date-type="accepted"><day>21</day><month>3</month><year>2008</year></date></history><permissions><copyright-year>2008</copyright-year><copyright-holder>Molecular Vision</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><sec><title>Purpose</title><p>Our previous work identified 23 low molecular weight (&#x0003c;3.5 kDa) crystallin peptides in the urea-soluble fractions of normal young, normal aged, and aged cataract human lenses. We found that one of these crystallin fragments, &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide (SDAYHIERLMSFRPIC), that are present in aged and cataract lens, increased the scattering of light by &#x003b2;- and &#x003b3;-crystallins and alcohol dehydrogenase (ADH) and also reduced the chaperone-like activity of &#x003b1;B-crystallin. The present study was performed to identify the interacting sites of the &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide in &#x003b1;B-crystallin.</p></sec><sec sec-type="methods"><title>Methods</title><p>&#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide was first derivatized with sulfo-succinimidyl-2-[6-(biotinamido)-2-{p-azidobenzamido}-hexanoamido] ethyl-1&#x02013;3 dithio propionate (sulfo-SBED), a photoactivable, heterotrifunctional biotin-containing cross-linker. The biotin-derivatized peptide was then incubated with &#x003b1;B-crystallin at 37&#x000a0;&#x000b0;C for 2 h to allow complex formation followed by photolysis to facilitate the transfer of the biotin label from the peptide to &#x003b1;B-crystallin. Label transfer was confirmed by western blot, and the labeled &#x003b1;B-crystallin was digested with trypsin. Tryptic peptides from &#x003b1;B-crystallin carrying the biotin label were purified by avidin affinity chromatography, and &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide interacting sites in &#x003b1;B-crystallin were identified by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry (MALDI-TOF MS) and nanospray quadrupole time-of-flight mass spectrometry (QqTOF MS/MS).</p></sec><sec><title>Results</title><p>We found that the &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide interacted with &#x003b1;B-crystallin regions <sup>70</sup>LEKDR<sup>74</sup>, <sup>83</sup>HFSPEELKVK<sup>92</sup>, <sup>91</sup>VKVLGDVIEVHGK<sup>103</sup>, <sup>93</sup>VLGDVIEVHGKHEER<sup>107</sup>, and <sup>121</sup>KYR<sup>123</sup>, which are part of the &#x003b1;-crystallin domain, and were previously shown to be part of the functional chaperone site in &#x003b1;B-crystallin. The &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide also interacted with regions at the COOH-terminal extension of &#x003b1;B-crystallin, <sup>150</sup>KQVSGPER<sup>157</sup>, <sup>164</sup>EEKPAVTAAPK<sup>174</sup>, and <sup>164</sup>EEKPAVTAAPKK<sup>175</sup>. When two of the hydrophobic residues of &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide were replaced with hydrophilic residues, the resulting substituted peptide, SDADHGERLMSFRPIC, did not show the anti-chaperone property.</p></sec><sec><title>Conclusions</title><p>This study confirmed the interactions between a low molecular weight peptide derived from &#x003b2;A3/A1-crystallin found in aged and cataract lenses and &#x003b1;B-crystallin. The binding of &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide to the chaperone site and the COOH-terminal extension of &#x003b1;B-crystallin may explain its anti-chaperone property.</p></sec></abstract><custom-meta-wrap><custom-meta><meta-name>f1-style</meta-name><meta-value>two-thirds</meta-value></custom-meta><custom-meta><meta-name>f2-style</meta-name><meta-value>two-thirds</meta-value></custom-meta><custom-meta><meta-name>f3-style</meta-name><meta-value>two-thirds</meta-value></custom-meta><custom-meta><meta-name>f4-style</meta-name><meta-value>two-thirds</meta-value></custom-meta><custom-meta><meta-name>f5-style</meta-name><meta-value>two-thirds</meta-value></custom-meta><custom-meta><meta-name>GalleyStatus</meta-name><meta-value>Export to XML</meta-value></custom-meta></custom-meta-wrap></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Human lens crystallins are organized into three classes, &#x003b1;-, &#x003b2;-, and &#x003b3;-crystallins, based on sequence homology and the size of aggregates isolated under physiologic conditions. Since lens crystallins undergo little or no turnover, there is opportunity for numerous post-translational modifications as the lens ages [<xref ref-type="bibr" rid="r1">1</xref>-<xref ref-type="bibr" rid="r4">4</xref>]. Some modifications of lens crystallins identified in young clear lenses may reflect normal development and maturation of the lens [<xref ref-type="bibr" rid="r5">5</xref>,<xref ref-type="bibr" rid="r6">6</xref>] whereas other modifications associated with aged lenses- such as deamidation, phosphorylation, truncation, glycation, oxidation, and cross-linking could negatively impact crystallin conformation, aggregation state, or solubility, resulting in increased light scattering and eventual loss of transparency in aged lenses [<xref ref-type="bibr" rid="r7">7</xref>-<xref ref-type="bibr" rid="r10">10</xref>].</p><p>In comparison to normal lenses, cataract lenses show greater fragmentation of crystallins due to proteolysis [<xref ref-type="bibr" rid="r1">1</xref>,<xref ref-type="bibr" rid="r11">11</xref>-<xref ref-type="bibr" rid="r13">13</xref>]. Increased crystallin fragmentation has also been reported in aged and cataract lenses of non-human species [<xref ref-type="bibr" rid="r6">6</xref>,<xref ref-type="bibr" rid="r14">14</xref>-<xref ref-type="bibr" rid="r17">17</xref>]. It has been reported that proteolysis may be a contributing factor in the insolubilization of crystallins occurring during normal maturation of lens or during cataract formation in human and bovine lenses [<xref ref-type="bibr" rid="r18">18</xref>]. It has been shown that the fragments of &#x003b2;A3/A1- and &#x003b2;B1-crystallins are selectively insolubilized during cataract development compared to normal aging [<xref ref-type="bibr" rid="r13">13</xref>]. These authors also reported increased crystallin truncation, the deamidation of Asn to Asp residues, and the oxidation of a Trp residue in cataract lenses.</p><p>Several proteolytic enzymes have been shown to play a role in aging of the lens and cataract formation [<xref ref-type="bibr" rid="r19">19</xref>-<xref ref-type="bibr" rid="r25">25</xref>]. Activities of several peptidases were reported to be highest in the outer cortical fibers and decreased to one half or below in the inner cortical fibers and nucleus. An inverse correlation between peptidase activities and the amount of crystallin fragments was observed in different regions of the lens. The amount of crystallin fragments and the amount of water-insoluble proteins were greater in the lens nucleus than in the outer cortical fibers [<xref ref-type="bibr" rid="r21">21</xref>]. An age-dependent decline in proteasome activity and a concomitant accumulation of modified proteins in human lens has been reported earlier [<xref ref-type="bibr" rid="r26">26</xref>]. Increased opacification of the lens nucleus in cataract was significantly correlated with decreased peptidase activities of the proteasome [<xref ref-type="bibr" rid="r27">27</xref>]. Although a protein oxidation reaction may render the protein susceptible to proteolysis, heavily oxidized proteins appear to first aggregate (via new hydrophobic and ionic bonds) and then to form covalent cross-links that make them highly resistant to proteolysis by 20S proteasome [<xref ref-type="bibr" rid="r28">28</xref>]. In fact, these aggregated, cross-linked oxidized proteins actually bind to the 20S proteasome and inhibit its ability to degrade the oxidized forms of other proteins [<xref ref-type="bibr" rid="r29">29</xref>].</p><p>Low molecular weight crystallin fragments have been isolated and characterized from both the water-soluble and water-insoluble fractions of the lens with greater prevalence in the water-insoluble fractions [<xref ref-type="bibr" rid="r11">11</xref>,<xref ref-type="bibr" rid="r21">21</xref>,<xref ref-type="bibr" rid="r30">30</xref>-<xref ref-type="bibr" rid="r32">32</xref>]. As many as 13 crystallin fragments with molecular masses between 3 and 17 kDa and originating from &#x003b1;-, &#x003b2;-, and &#x003b3;-crystallins have been isolated from the water-soluble, high molecular weight aggregates of 60-80-year-old human lenses [<xref ref-type="bibr" rid="r31">31</xref>]. Accumulation of such crystallin fragments may be a cause for age-related lens opacity. It has been hypothesized that the interaction of short peptides derived from crystallins with lens proteins may increase the formation of high molecular weight aggregates and the scattering of light [<xref ref-type="bibr" rid="r33">33</xref>]. Though it is hypothesized that cataract develops as a result of improper interaction of crystallin fragments generated by proteolysis [<xref ref-type="bibr" rid="r25">25</xref>], the underlying mechanism is not clear. Earlier work by our group has shown that in vitro-oxidized crystallin peptides enhance the aggregation of &#x003b2;<sub>L</sub>-crystallin and &#x003b3;-crystallin and also exhibit anti-chaperone-like properties [<xref ref-type="bibr" rid="r33">33</xref>-<xref ref-type="bibr" rid="r35">35</xref>]. Interaction of peptide fragments with lens proteins and their aggregation-enhancing nature may have some implications for age-related cataract formation.</p><p>Recent studies in our laboratory have revealed the presence of 23 low molecular weight (&#x0003c;3.5 kDa) peptides in the urea-soluble fractions of normal young, normal aged, and aged cataract human lenses, and the amount of crystallin fragments was found to increase with age [<xref ref-type="bibr" rid="r36">36</xref>]. Out of these 23 peptides, 15 were derived from &#x003b1;A- and &#x003b1;B-crystallin. Most of the 15 came from the NH<sub>2</sub>-terminal region, a few from the &#x003b1;-crystallin domain, and none from the COOH-terminal extension. Two crystallin peptides predominant in the nucleus of aged lens and cataract lens but not in young lens, &#x003b1;B<sub>1&#x02013;18</sub> (MDIAIHHPWIRRPFFPFH, GenBank <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&#x00026;id=4503057">NP_001876</ext-link>) and &#x003b2;A3/A1<sub>102&#x02013;117</sub> (SD(N)AYHIERLMSFRPIC, GenBank <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&#x00026;id=12056461">NP_005199</ext-link>), increased the molecular mass, polydispersity, and hydrodynamic radius of &#x003b1;A- and &#x003b1;B-crystallins [<xref ref-type="bibr" rid="r36">36</xref>]. Our study also showed that the peptides, &#x003b1;B<sub>1&#x02013;18</sub> and &#x003b2;A3/A1<sub>102&#x02013;117</sub>, increased the scattering of light by &#x003b2;- and &#x003b3;-crystallins and alcohol dehydrogenase (ADH) and also reduced the chaperone-like activity of &#x003b1;-crystallin.</p><p>The present study was undertaken to identify the binding sites for the &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide in &#x003b1;B-crystallin. We used the photoactive cross-linker sulfo-SBED (sulfo-succinimidyl-2-[6-(biotinamido)-2-{p-azidobenzamido}-hexanoamido] ethyl-1&#x02013;3 dithio propionate) [<xref ref-type="bibr" rid="r37">37</xref>] to confirm the interaction between &#x003b1;B-crystallin and the &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide. The &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide interacting sites in &#x003b1;B-crystallin are reported here.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Reagents</title><p>Trypsin gold (mass spectrometry grade) was purchased from Promega Corporation (Madison, WI). Sulfo-SBED, immobilized monomeric avidin kit, and micro-bicinchoninic acid (BCA) protein assay kit were procured from Pierce (Rockford, IL). Trypsin inhibitor, TLCK (N &#x003b1;-p-tosyl-L-lysine chloromethyl ketone), was obtained from Sigma Chemical Company (St. Louis, MO). The &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide, SDAYHIERLMSFRPIC, and the substituted peptide, SDADHGERLMSFRPIC (in which the tyrosine and isoleucine corresponding to 105 and 107 in &#x003b2;A3/A1-crystallin are replaced by aspartate and by glycine, respectively), were synthesized at the University of Missouri core facility and purified by HPLC. Their masses (1936.9 Da and 1833 Da, respectively) were ascertained by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry (MALDI-TOF MS). Blotting grade avidin-horseradish peroxidase conjugate was obtained from Bio-Rad Laboratories (Hercules, CA). Bovine &#x003b2;<sub>L</sub>-crystallin was isolated from lens extract using the procedure described earlier [<xref ref-type="bibr" rid="r35">35</xref>]. All other chemicals were of analytical grade.</p></sec><sec><title>Synthesis of recombinant human &#x003b1;B-crystallin</title><p>Human &#x003b1;B-crystallin cDNA (obtained from J.M. Petrash, Washington University, St. Louis, MO) was cloned into the pET-23d (+) vector (Novagen, Madison, WI), and the recombinant protein was expressed in <italic>Escherichia coli</italic> BL21(DE3) pLysS cells (Invitrogen, Carlsbad, CA) as described earlier [<xref ref-type="bibr" rid="r38">38</xref>]. The protein was purified by size exclusion chromatography followed by ion-exchange chromatography as described previously [<xref ref-type="bibr" rid="r39">39</xref>].</p><fig id="f1" fig-type="figure" position="float"><label>Figure 1</label><caption><p>Aggregation-enhancing and anti-chaperone property of &#x003b2;A3/A1<sub>102-117</sub> peptide. <bold>A</bold>: The effect of the &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide (SDAYHIERLMSFRPIC) and the substituted peptide (SDADHGERLMSFRPIC) on thermal aggregation of &#x003b2;<sub>L</sub>-crystallin shown. &#x003b2;<sub>L</sub>-crystallin (100 &#x003bc;g) was incubated at 55 &#x000b0;C with 60 &#x003bc;g of the peptides for 60 min. &#x003b2;A3/A1<sub>102-117</sub> peptide enhanced the light scattering by denaturing &#x003b2;<sub>L</sub>-crystallin whereas the substituted peptide did not. A, &#x003b2;<sub>L</sub>-crystallin; B, &#x003b2;<sub>L</sub>-crystallin + &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide; C, &#x003b2;<sub>L</sub>-crystallin + substituted peptide; D, &#x003b2;A3/A1<sub>102&#x02013;117</sub> or substituted peptide alone. <bold>B</bold>: The effect of &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide (SDAYHIERLMSFRPIC) and the substituted peptide (SDADHGERLMSFRPIC) on the chaperone-like activity of &#x003b1;B-crystallin against denaturing &#x003b2;<sub>L</sub>-crystallin is illustrated. &#x003b2;<sub>L</sub>-crystallin (100 &#x003bc;g) was incubated at 55 &#x000b0;C in the presence of 5 &#x003bc;g of &#x003b1;B-crystallin with or without 60 &#x003bc;g of the peptides for 60 min. In the presence of &#x003b2;A3/A1<sub>102-117</sub> peptide, the chaperone-like activity of &#x003b1;B-crystallin against denaturing &#x003b2;<sub>L</sub>-crystallin was lost. The substituted peptide however, did not decrease the chaperone-like activity of &#x003b1;B-crystallin. A, &#x003b2;<sub>L</sub>-crystallin; B, &#x003b2;<sub>L</sub>-crystallin + &#x003b1;B-crystallin; C, &#x003b2;<sub>L</sub>-crystallin + &#x003b1;B-crystallin + &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide; D, &#x003b2;<sub>L</sub>-crystallin + &#x003b1;B-crystallin + substituted peptide; E, &#x003b1;B-crystallin + &#x003b2;A3/A1<sub>102&#x02013;117</sub> or substituted peptide.</p></caption><graphic xlink:href="mv-v14-666-f1"/></fig></sec><sec><title>Effect of &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide on the thermal aggregation of &#x003b2;<sub>L</sub>-crystallin and the chaperone function of &#x003b1;B-crystallin</title><p>The &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide (SDAYHIERLMSFRPIC) as well as the substituted peptide (SDADHGERLMSFRPIC) were dissolved in 50&#x000a0;&#x003bc;l of DMSO and diluted to 0.5&#x000a0;ml with 0.05 M phosphate buffer containing 0.15 M NaCl (pH 7.4), hereafter referred to as phosphate buffered saline (PBS). The peptide concentration was measured using the micro-BCA assay method. Thermal aggregation assay of bovine &#x003b2;<sub>L</sub>-crystallin and chaperone assay of &#x003b1;B-crystallin were performed according to the method previously described [<xref ref-type="bibr" rid="r35">35</xref>]. Briefly, substrate protein, &#x003b2;<sub>L</sub>-crystallin (100&#x000a0;&#x003bc;g), was heat-denatured at 55&#x000a0;&#x000b0;C in 1&#x000a0;ml of PBS for 60 min in the presence or absence of &#x003b1;B-crystallin (5&#x000a0;&#x003bc;g) and the &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide or the substituted peptide (60&#x000a0;&#x003bc;g). Aggregation was monitored by recording the light scattering at 360 nm as a function of time at 55&#x000a0;&#x000b0;C in a Shimadzu spectrophotometer equipped with a temperature-controlled multicell transporter.</p><fig id="f2" fig-type="figure" position="float"><label>Figure 2</label><caption><p>Chaperone-like activity of &#x003b1;B-crystallin-&#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide complex against denaturing &#x003b2;<sub>L</sub>-crystallin. &#x003b2;<sub>L</sub>-crystallin (100 &#x003bc;g) was incubated at 55 &#x000b0;C in presence of 5 &#x003bc;g and 10 &#x003bc;g of &#x003b1;B-crystallin or &#x003b1;B-crystallin-&#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide complex for 60 min and the light scattering was measured as described under methods.&#x000a0;The results show that&#x000a0;prior interaction of &#x003b1;B-crystallin with &#x003b2;A3/A1<sub>102-117</sub> peptide diminished its chaperone-like activity against denaturing &#x003b2;<sub>L</sub>-crystallin. <bold>A</bold>, &#x003b2;<sub>L</sub>-crystallin; <bold>B</bold>, &#x003b2;<sub>L</sub>-crystallin + 5 &#x003bc;g &#x003b1;B-crystallin; <bold>C</bold>, &#x003b2;<sub>L</sub>-crystallin + 10 &#x003bc;g &#x003b1;B-crystallin; <bold>D</bold>, &#x003b2;<sub>L</sub>-crystallin + 5 &#x003bc;g &#x003b1;B-crystallin-&#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide complex; <bold>E</bold>, &#x003b2;<sub>L</sub>-crystallin + 10 &#x003bc;g &#x003b1;B-crystallin-&#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide complex; <bold>F</bold>, &#x003b1;B-crystallin or &#x003b1;B-crystallin-&#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide complex alone. Insert: Relative light scattering by &#x003b2;<sub>L</sub>-crystallin in presence of &#x003b1;B-crystallin or &#x003b1;B-crystallin-&#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide complex. Scattering by &#x003b2;<sub>L</sub>-crystallin alone at 60 min is considered to be 100%.</p></caption><graphic xlink:href="mv-v14-666-f2"/></fig></sec><sec><title>Effect of pre-incubation with &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide on the chaperone function of &#x003b1;B-crystallin</title><p>To determine whether prior binding of the &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide alters the chaperone-like activity of &#x003b1;B-crystallin toward denaturing proteins, 50&#x000a0;&#x003bc;g of &#x003b1;B-crystallin was incubated with 100&#x000a0;&#x003bc;g of &#x003b2;A3/A1<sub>102&#x02013;117</sub> in a total volume of 0.2&#x000a0;ml of PBS at 37&#x000a0;&#x000b0;C for 12 h. A sample containing &#x003b1;B-crystallin alone served as a control. After the incubation, samples were briefly centrifuged to separate any visible precipitate. The supernatant was injected into a TSK G5000PW<sub>XL</sub> (Tosoh Bioscience, Montgomeryville, PA) size exclusion column fitted to an HPLC system with an ultraviolet (UV) detector and equilibrated with PBS. The peak containing the &#x003b1;B-crystallin-peptide complex was pooled (free of unbound peptide) and used in the chaperone assay as described in the previous section.</p><fig id="f3" fig-type="figure" position="float"><label>Figure 3</label><caption><p>Western blot and SDS&#x02013;PAGE of &#x003b1;B-crystallin treated with sulfo-SBED-derivatized &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide and substituted peptide. The blots were probed with avidin-horseradish peroxidase conjugate, and detection was done using a mixture of 4-chloronaphthol and hydrogen peroxide. Western blot lanes 1 and 2 correspond to SDS&#x02013;PAGE of lanes 4 and 5 stained with coomassie blue. Lane 1- &#x003b1;B-crystallin interacted with sulfo-SBED-derivatized &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide; Lane 2- &#x003b1;B-crystallin interacted with sulfo-SBED-derivatized substituted peptide; Lane 3- Molecular weight markers; Lane 4- &#x003b1;B-crystallin interacted with sulfo-SBED-derivatized &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide; Lane 5- &#x003b1;B-crystallin interacted with sulfo-SBED-derivatized substituted peptide. The arrow indicates the position of &#x003b1;B-crystallin.</p></caption><graphic xlink:href="mv-v14-666-f3"/></fig></sec><sec><title>Identification of &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide binding sites in &#x003b1;B-crystallin</title><p>To identify the &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide binding sites in &#x003b1;B-crystallin, the purified peptide was derivatized with sulfo-SBED, a biotin-containing and photoactivable as well as heterotrifunctional and amine-group specific reagent [<xref ref-type="bibr" rid="r37">37</xref>]. The procedure described by the supplier (Pierce) was used. In brief, 1.78&#x000a0;mg of &#x003b2;A3/A1 peptide was dissolved in 10&#x000a0;&#x003bc;l DMSO and the volume was made up to 50&#x000a0;&#x003bc;l with PBS. Then, 2.5&#x000a0;mg of sulfo-SBED dissolved in 10&#x000a0;&#x003bc;l DMSO and made up to 50&#x000a0;&#x003bc;l with PBS was added to the peptide, and the final volume of the reaction mixture was made up to 0.3&#x000a0;ml with phosphate buffer. This achieved a threefold molar excess of the sulfo-SBED over the peptide. The mixture was incubated in the dark at room temperature for 45 min. The unreacted sulfo-SBED was removed by dialyzing extensively against PBS using a 1000 Da cut-off membrane. Similarly, the substituted peptide, SDADHGERLMSFRPIC, was derivatized with sulfo-SBED for use in the interaction studies.</p><p>To study the interaction between the sulfo-SBED-derivatized &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide (or the substituted peptide) and &#x003b1;B-crystallin, 0.25&#x000a0;mg of the derivatized peptide was incubated with 0.25&#x000a0;mg of human recombinant &#x003b1;B-crystallin at 37&#x000a0;&#x000b0;C for 2 h. Subsequently, the mixture was filtered in a 10,000 Da cut-off centrifugal filter to remove unbound peptide (all steps were performed in the dark). Following this, the sample was photolyzed on an ice bath for 15 min using a UV lamp (365 nm) held at a distance of 2 cm from the sample. Transfer of the biotin label from the sulfo-SBED-derivatized peptide to &#x003b1;B-crystallin was confirmed by SDS&#x02013;PAGE followed by western blot. The intensities of labeled bands in blots were quantified using Kodak 1D image analysis software (Eastman Kodak Company, Rochester, NY). The labeled &#x003b1;B-crystallin was then reduced by DTT and alkylated with iodoacetamide. Following this, the sample was dialyzed extensively for 24 h against 50&#x000a0;mM Tris (pH 7.6) containing 1&#x000a0;mM CaCl<sub>2</sub> using a 15,000 Da cut-off membrane and digested by mass spectrometry grade trypsin (1:25 w/w) at 37&#x000a0;&#x000b0;C for 12 h. Trypsin digestion was terminated by the addition of the trypsin inhibitor, TLCK (1&#x000a0;mM); the sample was filtered through a microcon 10 kDa filter (Millipore, Bedford, MA), and the filtrate was collected. Trypsin-digested &#x003b1;B-crystallin peptides having the biotin group derived from the sulfo-SBED cross-linker were isolated by Pierce immobilized monomeric avidin affinity gel chromatography [<xref ref-type="bibr" rid="r37">37</xref>]. The biotin-labeled peptides were concentrated by Speed Vac, desalted by C-18 spin columns, and analyzed in an Applied Biosystems 4700 MALDI TOF/TOF mass spectrometer. The sequences of the labeled peptides were determined by nanospray quadrupole time-of-flight mass spectrometry (QqTOF MS/MS).</p><fig id="f4" fig-type="figure" position="float"><label>Figure 4</label><caption><p>MALDI-TOF MS spectrum of biotin-labeled &#x003b1;B-crystallin tryptic peptides purified by avidin affinity chromatography. Sulfo-SBED-derivatized &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide was allowed to interact with &#x003b1;B-crystallin then was photolyzed and digested with trypsin as described under Methods before chromatography. Masses of the &#x003b1;B-crystallin tryptic peptides carrying the biotin label are indicated in the figure. The sequences of these peptides&#x000a0;are shown in <xref ref-type="fig" rid="f5">Figure 5</xref>.</p></caption><graphic xlink:href="mv-v14-666-f4"/></fig></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Effect of &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide on the thermal aggregation of bovine &#x003b2;<sub>L</sub>-crystallin and the chaperone-like action of &#x003b1;B-crystallin</title><p>The &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide found in aged lenses is present in both deamidated (at Asn<sub>103</sub>) and non-deamidated forms in vivo. Both the native peptide and the deamidated form of the same peptide displayed similar anti-chaperone activity (data not shown here). In this study, we used the deamidated form of the peptide. Thermal denaturation of &#x003b2;<sub>L</sub>-crystallin at 55&#x000a0;&#x000b0;C resulted in aggregation and light scattering. The addition of the &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide to the incubation mixture resulted in increased light scattering by &#x003b2;<sub>L</sub>-crystallin by 58% whereas the substituted peptide increased the light scattering only by 4% at 60 min. The &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide by itself did not scatter light (<xref ref-type="fig" rid="f1">Figure 1A</xref>). When the &#x003b2;<sub>L</sub>-crystallin was heat-denatured in the presence of &#x003b1;B-crystallin, the light scattering was decreased by 41% at 60 min due to the chaperone-like action of &#x003b1;B-crystallin. However, when &#x003b2;<sub>L</sub>-crystallin was denatured in the presence of &#x003b1;B-crystallin and &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide, the light scattering increased by 20% showing the decreased chaperone action of &#x003b1;B-crystallin. The substituted peptide, on the other hand, caused a slight improvement in the chaperone action of &#x003b1;B-crystallin. The light scattering by denatured &#x003b2;<sub>L</sub>-crystallin was decreased by 53% in the presence of &#x003b1;B-crystallin and substituted peptide (<xref ref-type="fig" rid="f1">Figure 1B</xref>). The &#x003b1;B-crystallin-&#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide complex showed a lowered ability to prevent thermal aggregation of &#x003b2;<sub>L</sub>-crystallin. This complex (5&#x000a0;&#x003bc;g) decreased the light scattering by heat-denatured &#x003b2;<sub>L</sub>-crystallin at 60 min by only 3% (<xref ref-type="fig" rid="f2">Figure 2</xref>, curve D) as opposed to a 51% decrease caused by an equivalent amount of the control, &#x003b1;B-crystallin (<xref ref-type="fig" rid="f2">Figure 2</xref>, curve B). When a higher concentration of &#x003b1;B-crystallin-&#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide complex (10&#x000a0;&#x003bc;g) was used in the assay, it caused only a 24% decrease in light scattering (<xref ref-type="fig" rid="f2">Figure 2</xref>, curve E) compared to the 81% decrease caused by an equivalent amount of the control, &#x003b1;B-crystallin (<xref ref-type="fig" rid="f2">Figure 2</xref>, curve C).</p><fig id="f5" fig-type="figure" position="float"><label>Figure 5</label><caption><p>Amino acid sequence of &#x003b1;B-crystallin showing the &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide interacting sites (underlined). The chaperone region previously identified by us is shaded in gray. Biotin-labeled &#x003b1;B-crystallin peptides were analyzed by MALDI-TOF MS, and their sequences were assigned by nanospray QqTOF MS/MS. The masses of the biotin-labeled &#x003b1;B-crystallin peptides are shown adjacent to their sequences. *NH<sub>2</sub>-terminal peptide was consistently observed in the MALDI-TOF MS without a sulfo-SBED label. This peptide may be interacting with other labeled peptides and co-eluting during the monomeric avidin purification step.</p></caption><graphic xlink:href="mv-v14-666-f5"/></fig></sec><sec><title>Identification of &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide binding sites in recombinant &#x003b1;B-crystallin</title><p>Photoinsertion of the biotin label from the derivatized &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide to &#x003b1;B-crystallin was confirmed by SDS&#x02013;PAGE and western blot analysis (<xref ref-type="fig" rid="f3">Figure 3</xref>, lane 1). The derivatized substituted peptide incorporated the biotin label into &#x003b1;B-crystallin to a significantly lesser extent than the native peptide (about 1.2% of the band intensity in western blot as compared to &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide) as seen in <xref ref-type="fig" rid="f3">Figure 3</xref>, lane 2.</p><p>To identify the &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide interacting sites in &#x003b1;B-crystallin, the tryptic digest of &#x003b1;B-crystallin containing the biotin-labeled peptides was enriched by immobilized monomeric avidin affinity gel chromatography. The masses of the labeled peptides were determined by MALDI TOF/TOF MS. Since sulfo-SBED contains a cleavable disulfide bond, reduction and alkylation of the labeled &#x003b1;B-crystallin with iodoacetamide will add a net mass of 603.22 Da to the mass of the &#x003b1;B-crystallin-derived peptide containing the biotin label. Before assigning the amino acid sequence for each biotin-labeled &#x003b1;B-crystallin peptide, the presence of biotin label in those peptides was confirmed by detection of the fragment ions generating specifically from sulfo-SBED during MS/MS analysis [<xref ref-type="bibr" rid="r34">34</xref>]. MALDI-TOF MS spectra of biotin-labeled &#x003b1;B-crystallin peptides obtained from monomeric avidin affinity column is shown in <xref ref-type="fig" rid="f4">Figure 4</xref>. The peptide peaks labeled in <xref ref-type="fig" rid="f4">Figure 4</xref> were analyzed further by nanospray QqTOF MS/MS. The amino acid sequence of those peptides is indicated in the &#x003b1;B-crystallin sequence in <xref ref-type="fig" rid="f5">Figure 5</xref>. The amino acid sequences of tryptic digest peptides of &#x003b1;B-crystallin carrying the biotin label and their masses (in parentheses) were <sup>70</sup>LEKDR<sup>74</sup> (1263.64 Da), <sup>83</sup>HFSPEELKVK<sup>92</sup> (1816.93 Da), <sup>91</sup>VKVLGDVIEVHGK<sup>103</sup> (1996.06 Da), <sup>93</sup>VLGDVIEVHGKHEER<sup>107</sup> (2320.26 Da), <sup>121</sup>KYR<sup>123</sup> (1069.51 Da), <sup>150</sup>KQVSGPER<sup>157</sup> (1503.75 Da), <sup>164</sup>EEKPAVTAAPK<sup>174</sup> (1743.86 Da), and <sup>164</sup>EEKPAVTAAPKK<sup>175</sup> (1871.99 Da). A peptide with a mass of 1388.77 Da without any modifications, corresponding to residues 1&#x02013;11 in &#x003b1;B-crystallin, was also found among the purified peptides.</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>The presence of crystallin fragments in water-soluble and water-insoluble fractions of lens proteins has been known for some years [<xref ref-type="bibr" rid="r11">11</xref>,<xref ref-type="bibr" rid="r40">40</xref>]. We first suggested that anti-chaperone peptides accumulating in vivo may be contributing to lens opacification during aging [<xref ref-type="bibr" rid="r33">33</xref>]. Recent studies in our laboratory have revealed the presence of 23 low molecular weight (&#x0003c;3.5 kDa) peptides in the urea-soluble fractions of normal young, normal aged, and aged cataract human lenses, and the amount of crystallin fragments was found to increase with age [<xref ref-type="bibr" rid="r36">36</xref>]. Our study also showed that &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide, found in aged and cataract lens, increased the scattering of light by &#x003b2;- and &#x003b3;-crystallins and alcohol dehydrogenase (ADH). &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide also exhibited an anti-chaperone property by decreasing the ability of &#x003b1;-crystallin to prevent aggregation of &#x003b2;- and &#x003b3;-crystallins and non-crystallin protein substrates, a process believed to be essential for maintenance of lens transparency [<xref ref-type="bibr" rid="r36">36</xref>].</p><p>The present study has confirmed the aggregation-enhancing property of the &#x003b2;A3/A1-crystallin-derived peptide, <sup>102</sup>SDAYHIERLMSFRPIC<sup>117</sup>, since it promoted the aggregation of &#x003b2;<sub>L</sub>-crystallin during thermal denaturation (<xref ref-type="fig" rid="f1">Figure 1A</xref>). The presence of this peptide in the assay mixture reduced the ability of &#x003b1;B-crystallin to protect &#x003b2;<sub>L</sub>-crystallin against thermal aggregation (<xref ref-type="fig" rid="f1">Figure 1B</xref>). Since the &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide interacts with both &#x003b2;<sub>L</sub>-crystallin and &#x003b1;B-crystallin, the enhanced light scattering observed in its presence may be due to a combination of its interaction with the substrate as well as the chaperone protein. To confirm the anti-chaperone nature of the peptide, we pretreated &#x003b1;B-crystallin with &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide and separated the complex from the free peptide. The &#x003b1;B-crystallin-&#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide complex showed a considerable loss of chaperone-like activity against heat-denatured &#x003b2;<sub>L</sub>-crystallin (<xref ref-type="fig" rid="f2">Figure 2</xref>). Since free peptide was removed before the assay, we believe that the decreased chaperoning ability of &#x003b1;B-crystallin was specifically due to the binding of the peptide to &#x003b1;B-crystallin. When the &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide was derivatized with sulfo-SBED, incubated with &#x003b1;B-crystallin, and photolyzed, the biotin label transferred to &#x003b1;B-crystallin (<xref ref-type="fig" rid="f3">Figure 3</xref>, lane 1). The MALDI-TOF MS of the peptides derived from the &#x003b1;B-crystallin by trypsin digestion showed the presence of biotin from sulfo-SBED in several peptides (<xref ref-type="fig" rid="f4">Figure 4</xref>). The identity of those peptides was obtained by sequencing in a nanospray QqTOF mass spectrometer. The sites on &#x003b1;B-crystallin where the label was observed (<xref ref-type="fig" rid="f5">Figure 5</xref>) included the sequences, <sup>70</sup>LEKDR<sup>74</sup> and <sup>83</sup>HFSPEELKVK<sup>92</sup>. Earlier, we showed that <sup>73</sup>DRFSVNLDVKHFSPEELKVK<sup>92</sup> is one of the well characterized functional chaperone sites in &#x003b1;B-crystallin [<xref ref-type="bibr" rid="r41">41</xref>]. Therefore, we can conclude that the anti-chaperone peptide &#x003b2;A3/A1<sub>102&#x02013;117</sub> binds to &#x003b1;B-crystallin at the chaperone site. The binding of the &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide to this substrate-binding site in &#x003b1;B-crystallin may have diminished the ability of the protein to effectively chaperone the denaturing &#x003b2;<sub>L</sub>-crystallin.</p><p>Other sites of interaction between the &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide and &#x003b1;B-crystallin included the sequences, <sup>91</sup>VKVLGDVIEVHGKHEER<sup>107</sup> and <sup>121</sup>KYR<sup>123</sup>. These sequences are part of the &#x003b1;-crystallin domain. Earlier, Arg<sub>120</sub> was shown to be important for the chaperone-like activity of &#x003b1;B-crystallin [<xref ref-type="bibr" rid="r42">42</xref>]. A recent study demonstrated that <sup>73</sup>DRFSVNLDVKHFS<sup>85</sup> and <sup>101</sup>HGKHEERQDE<sup>110</sup> sequences in &#x003b1;B-crystallin inhibited the fibrillation of disease-related amyloidogenic proteins including &#x003b1;-synuclein and amyloid-&#x003b2; [<xref ref-type="bibr" rid="r43">43</xref>]. Other binding sites of the &#x003b2;A3/A1peptide to &#x003b1;B-crystallin included the COOH-terminal region of <sup>150</sup>KQVSGPER<sup>157</sup> and <sup>164</sup>EEKPAVTAAPKK<sup>175</sup>. An earlier study has shown that mutations of the two terminal lysines (174 and 175) of &#x003b1;B-crystallin to leucine or glycine greatly reduced its chaperone-like activity. It was postulated that mutations in these two amino acids may have resulted in the COOH-terminus folding back on itself, losing its flexibility, and sterically hindering protein binding [<xref ref-type="bibr" rid="r44">44</xref>]. The COOH-terminal extensions of &#x003b1;-crystallins are considered polar, highly flexible, and solvent-exposed. These extensions also act as solubilizing agents for the relatively hydrophobic &#x003b1;-crystallin molecule and the high molecular weight complex that forms during the chaperone action [<xref ref-type="bibr" rid="r45">45</xref>].</p><p>&#x003b1;B-Crystallin with five amino acids deleted from its COOH-terminus was found in lenses of hereditary cataractous iCR/f rat, and this truncated crystallin showed decreased chaperone activity [<xref ref-type="bibr" rid="r46">46</xref>]. Protein pin array studies have identified <sup>157</sup>RTIPITRE<sup>164</sup> as one of the interactive sequences for chaperone activity in human &#x003b1;B-crystallin [<xref ref-type="bibr" rid="r47">47</xref>]. Deletion of the polar COOH-terminal sequence, <sup>155</sup>PERTIPITREE<sup>165</sup>, from human &#x003b1;B-crystallin resulted in poor solubility and limited or no chaperone activity against unfolding &#x003b2;<sub>L</sub>-crystallin, alcohol dehydrogenase, and citrate synthase. These results demonstrated the importance of the COOH-terminal residues in the recognition, selection, and maintenance of solubility of unfolding substrate proteins [<xref ref-type="bibr" rid="r48">48</xref>]. As identified by protein pin-array studies, the <sup>150</sup>KQVSGPER<sup>157</sup>, <sup>164</sup>EEKPAVTAAPK<sup>174</sup>, and <sup>164</sup>EEKPAVTAAPKK<sup>175</sup> sequences, which are identified as peptide interacting sites in &#x003b1;B-crystallin in the present study, overlap with sequences involved in dimerization and assembly of human &#x003b1;B-crystallin [<xref ref-type="bibr" rid="r49">49</xref>]. The binding of the &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide to the COOH-terminal extension of &#x003b1;B-crystallin in the present study may have interfered with substrate binding and decreased the chaperoning ability of the protein. Our recent studies showed that the &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide caused partial precipitation of &#x003b1;B-crystallin [<xref ref-type="bibr" rid="r36">36</xref>]. We believe that the peptide interaction at the COOH-terminal extension of &#x003b1;B-crystallin may have led to decreased flexibility and decreased solubilization potential of &#x003b1;B-crystallin. Additionally, the interactions between crystallins and low molecular weight peptides may limit the access of these peptides to peptidases, resulting in the accumulation of peptides with aging.</p><p>The substituted peptide we used in this study, SDADHGERLMSFRPIC, had two hydrophobic residues (tyrosine and isoleucine) replaced by hydrophilic (aspartate and glycine) residues. The substitution abolished the ability of the peptide to induce &#x003b2;<sub>L</sub>-crystallin aggregation (<xref ref-type="fig" rid="f1">Figure 1A</xref>) and to act as anti-chaperone (<xref ref-type="fig" rid="f1">Figure 1B</xref>). This suggests that the hydrophobic amino acids play a critical role in the interaction of the anti-chaperone peptide with &#x003b1;B-crystallin. The substituted peptide can also be considered a control peptide for the label transfer study. If there were any non-specific interactions between the derivatized substituted peptide and &#x003b1;B-crystallin, we would have seen a transfer of biotin to &#x003b1;B-crystallin following photolysis. The fact that the &#x003b1;B-crystallin incubated with derivatized substituted peptide showed only about 1.2% of the label transfer when compared to the derivatized &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide during the blotting experiments (<xref ref-type="fig" rid="f3">Figure 3</xref> lane 2) suggests that the non-specific interaction and label transfer was insignificant in this study.</p><p>In summary, this study confirmed the interactions between &#x003b2;A3/A1<sub>102&#x02013;117</sub> peptide and &#x003b1;B-crystallin. The binding of this peptide to regions critical for chaperone action of &#x003b1;B-crystallin may explain its anti-chaperone property. The modulation of structural and functional properties of crystallins by low molecular weight peptides may play an important role in protein aggregation and cataract formation.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work was supported by National Institutes of Health Grants EY11981, EY09855, EY14795 and a grant-in-aid from Research to Prevent Blindness.</p></ack><ref-list><title>References</title><ref id="r1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lampi</surname><given-names>KJ</given-names></name><name><surname>Ma</surname><given-names>Z</given-names></name><name><surname>Hanson</surname><given-names>SR</given-names></name><name><surname>Azuma</surname><given-names>M</given-names></name><name><surname>Shih</surname><given-names>M</given-names></name><name><surname>Shearer</surname><given-names>TR</given-names></name><name><surname>Smith</surname><given-names>DL</given-names></name><name><surname>Smith</surname><given-names>JB</given-names></name><name><surname>David</surname><given-names>LL</given-names></name></person-group><article-title>Age-related changes in human lens crystallins identified by two-dimensional electrophoresis and mass spectrometry.</article-title><source>Exp Eye Res</source><year>1998</year><volume>67</volume><fpage>31</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">9702176</pub-id></citation></ref><ref id="r2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harding</surname><given-names>JJ</given-names></name></person-group><article-title>Viewing molecular mechanisms of ageing through a lens.</article-title><source>Ageing Res Rev</source><year>2002</year><volume>1</volume><fpage>465</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">12067598</pub-id></citation></ref><ref id="r3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>Z</given-names></name><name><surname>Hanson</surname><given-names>SR</given-names></name><name><surname>Lampi</surname><given-names>KJ</given-names></name><name><surname>David</surname><given-names>LL</given-names></name><name><surname>Smith</surname><given-names>DL</given-names></name><name><surname>Smith</surname><given-names>JB</given-names></name></person-group><article-title>Age-related changes in human lens crystallins identified by HPLC and mass spectrometry.</article-title><source>Exp Eye Res</source><year>1998</year><volume>67</volume><fpage>21</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">9702175</pub-id></citation></ref><ref id="r4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lapko</surname><given-names>VN</given-names></name><name><surname>Cerny</surname><given-names>RL</given-names></name><name><surname>Smith</surname><given-names>DL</given-names></name><name><surname>Smith</surname><given-names>JB</given-names></name></person-group><article-title>Modifications of human betaA1/betaA3-crystallins include S-methylation, glutathiolation, and truncation.</article-title><source>Protein Sci</source><year>2005</year><volume>14</volume><fpage>45</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">15576560</pub-id></citation></ref><ref id="r5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miesbauer</surname><given-names>LR</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Smith</surname><given-names>DL</given-names></name><name><surname>Smith</surname><given-names>JB</given-names></name></person-group><article-title>Post-translational modifications of water-soluble human lens crystallins from young adults.</article-title><source>J Biol Chem</source><year>1994</year><volume>269</volume><fpage>12494</fpage><lpage>502</lpage><pub-id pub-id-type="pmid">8175657</pub-id></citation></ref><ref id="r6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Werten</surname><given-names>PJ</given-names></name><name><surname>Vos</surname><given-names>E</given-names></name><name><surname>De Jong</surname><given-names>WW</given-names></name></person-group><article-title>Truncation of betaA3/A1-crystallin during aging of the bovine lens; possible implications for lens optical quality.</article-title><source>Exp Eye Res</source><year>1999</year><volume>68</volume><fpage>99</fpage><lpage>103</lpage><pub-id pub-id-type="pmid">9986747</pub-id></citation></ref><ref id="r7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hoehenwarter</surname><given-names>W</given-names></name><name><surname>Klose</surname><given-names>J</given-names></name><name><surname>Jungblut</surname><given-names>PR</given-names></name></person-group><article-title>Eye lens proteomics.</article-title><source>Amino Acids</source><year>2006</year><volume>30</volume><fpage>369</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">16583312</pub-id></citation></ref><ref id="r8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bloemendal</surname><given-names>H</given-names></name><name><surname>de Jong</surname><given-names>W</given-names></name><name><surname>Jaenicke</surname><given-names>R</given-names></name><name><surname>Lubsen</surname><given-names>NH</given-names></name><name><surname>Slingsby</surname><given-names>C</given-names></name><name><surname>Tardieu</surname><given-names>A</given-names></name></person-group><article-title>Ageing and vision: structure, stability and function of lens crystallins.</article-title><source>Prog Biophys Mol Biol</source><year>2004</year><volume>86</volume><fpage>407</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">15302206</pub-id></citation></ref><ref id="r9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lund</surname><given-names>AL</given-names></name><name><surname>Smith</surname><given-names>JB</given-names></name><name><surname>Smith</surname><given-names>DL</given-names></name></person-group><article-title>Modifications of the water-insoluble human lens alpha-crystallins.</article-title><source>Exp Eye Res</source><year>1996</year><volume>63</volume><fpage>661</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">9068373</pub-id></citation></ref><ref id="r10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harrington</surname><given-names>V</given-names></name><name><surname>Srivastava</surname><given-names>OP</given-names></name><name><surname>Kirk</surname><given-names>M</given-names></name></person-group><article-title>Proteomic analysis of water insoluble proteins from normal and cataractous human lenses.</article-title><source>Mol Vis</source><year>2007</year><volume>13</volume><fpage>1680</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">17893670</pub-id></citation></ref><ref id="r11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>OP</given-names></name></person-group><article-title>Age-related increase in concentration and aggregation of degraded polypeptides in human lenses.</article-title><source>Exp Eye Res</source><year>1988</year><volume>47</volume><fpage>525</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">3181333</pub-id></citation></ref><ref id="r12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>OP</given-names></name><name><surname>Kirk</surname><given-names>MC</given-names></name><name><surname>Srivastava</surname><given-names>K</given-names></name></person-group><article-title>Characterization of covalent multimers of crystallins in aging human lenses.</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>10901</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">14623886</pub-id></citation></ref><ref id="r13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harrington</surname><given-names>V</given-names></name><name><surname>McCall</surname><given-names>S</given-names></name><name><surname>Huynh</surname><given-names>S</given-names></name><name><surname>Srivastava</surname><given-names>K</given-names></name><name><surname>Srivastava</surname><given-names>OP</given-names></name></person-group><article-title>Crystallins in water soluble-high molecular weight protein fractions and water insoluble protein fractions in aging and cataractous human lenses.</article-title><source>Mol Vis</source><year>2004</year><volume>10</volume><fpage>476</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">15303090</pub-id></citation></ref><ref id="r14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garber</surname><given-names>AT</given-names></name><name><surname>Goring</surname><given-names>D</given-names></name><name><surname>Gold</surname><given-names>RJ</given-names></name></person-group><article-title>Characterization of abnormal proteins in the soluble lens proteins of CatFraser mice.</article-title><source>J Biol Chem</source><year>1984</year><volume>259</volume><fpage>10376</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">6469970</pub-id></citation></ref><ref id="r15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shih</surname><given-names>M</given-names></name><name><surname>Lampi</surname><given-names>KJ</given-names></name><name><surname>Shearer</surname><given-names>TR</given-names></name><name><surname>David</surname><given-names>LL</given-names></name></person-group><article-title>Cleavage of beta crystallins during maturation of bovine lens.</article-title><source>Mol Vis</source><year>1998</year><volume>4</volume><fpage>4</fpage><pub-id pub-id-type="pmid">9485487</pub-id></citation></ref><ref id="r16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thampi</surname><given-names>P</given-names></name><name><surname>Hassan</surname><given-names>A</given-names></name><name><surname>Smith</surname><given-names>JB</given-names></name><name><surname>Abraham</surname><given-names>EC</given-names></name></person-group><article-title>Enhanced C-terminal truncation of alphaA- and alphaB-crystallins in diabetic lenses.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2002</year><volume>43</volume><fpage>3265</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">12356833</pub-id></citation></ref><ref id="r17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ueda</surname><given-names>Y</given-names></name><name><surname>Duncan</surname><given-names>MK</given-names></name><name><surname>David</surname><given-names>LL</given-names></name></person-group><article-title>Lens proteomics: the accumulation of crystallin modifications in the mouse lens with age.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2002</year><volume>43</volume><fpage>205</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">11773033</pub-id></citation></ref><ref id="r18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shih</surname><given-names>M</given-names></name><name><surname>David</surname><given-names>LL</given-names></name><name><surname>Lampi</surname><given-names>KJ</given-names></name><name><surname>Ma</surname><given-names>H</given-names></name><name><surname>Fukiage</surname><given-names>C</given-names></name><name><surname>Azuma</surname><given-names>M</given-names></name><name><surname>Shearer</surname><given-names>TR</given-names></name></person-group><article-title>Proteolysis by m-calpain enhances in vitro light scattering by crystallins from human and bovine lenses.</article-title><source>Curr Eye Res</source><year>2001</year><volume>22</volume><fpage>458</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">11584346</pub-id></citation></ref><ref id="r19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mathur</surname><given-names>P</given-names></name><name><surname>Gupta</surname><given-names>SK</given-names></name><name><surname>Wegener</surname><given-names>AR</given-names></name><name><surname>Breipohl</surname><given-names>W</given-names></name><name><surname>Ahrend</surname><given-names>MH</given-names></name><name><surname>Sharma</surname><given-names>YD</given-names></name><name><surname>Gupta</surname><given-names>YK</given-names></name><name><surname>Vajpayee</surname><given-names>RB</given-names></name></person-group><article-title>Comparison of various calpain inhibitors in reduction of light scattering, protein precipitation and nuclear cataract in vitro.</article-title><source>Curr Eye Res</source><year>2000</year><volume>21</volume><fpage>926</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">11262616</pub-id></citation></ref><ref id="r20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhan</surname><given-names>H</given-names></name><name><surname>Yamamoto</surname><given-names>Y</given-names></name><name><surname>Shumiya</surname><given-names>S</given-names></name><name><surname>Kunimatsu</surname><given-names>M</given-names></name><name><surname>Nishi</surname><given-names>K</given-names></name><name><surname>Ohkubo</surname><given-names>I</given-names></name><name><surname>Kani</surname><given-names>K</given-names></name></person-group><article-title>Peptidases play an important role in cataractogenesis: an immunohistochemical study on lenses derived from Shumiya cataract rats.</article-title><source>Histochem J</source><year>2001</year><volume>33</volume><fpage>511</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">12005022</pub-id></citation></ref><ref id="r21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>KK</given-names></name><name><surname>Kester</surname><given-names>K</given-names></name></person-group><article-title>Peptide hydrolysis in lens: role of leucine aminopeptidase, aminopeptidase III, prolyloligopeptidase and acylpeptidehydrolase.</article-title><source>Curr Eye Res</source><year>1996</year><volume>15</volume><fpage>363</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">8670735</pub-id></citation></ref><ref id="r22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Swaminathan</surname><given-names>S</given-names></name><name><surname>Chandrasekher</surname><given-names>G</given-names></name><name><surname>Venkataraman</surname><given-names>A</given-names></name><name><surname>Pattabiraman</surname><given-names>TN</given-names></name></person-group><article-title>Proteases and protease inhibitory activities in normal mammalian lenses and human cataractous lenses.</article-title><source>Biochem Med Metab Biol</source><year>1986</year><volume>35</volume><fpage>184</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">3518755</pub-id></citation></ref><ref id="r23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wride</surname><given-names>MA</given-names></name><name><surname>Geatrell</surname><given-names>J</given-names></name><name><surname>Guggenheim</surname><given-names>JA</given-names></name></person-group><article-title>Proteases in eye development and disease.</article-title><source>Birth Defects Res C Embryo Today</source><year>2006</year><volume>78</volume><fpage>90</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">16622853</pub-id></citation></ref><ref id="r24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Swanson</surname><given-names>AA</given-names></name><name><surname>Davis</surname><given-names>RM</given-names></name><name><surname>Meinhardt</surname><given-names>NC</given-names></name></person-group><article-title>Proteases in human lenses and their possible significance.</article-title><source>Curr Eye Res</source><year>1985</year><volume>4</volume><fpage>43</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">2858361</pub-id></citation></ref><ref id="r25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>David</surname><given-names>LL</given-names></name><name><surname>Shearer</surname><given-names>TR</given-names></name></person-group><article-title>Role of proteolysis in lenses: a review.</article-title><source>Lens Eye Toxic Res</source><year>1989</year><volume>6</volume><fpage>725</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">2562121</pub-id></citation></ref><ref id="r26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Viteri</surname><given-names>G</given-names></name><name><surname>Carrard</surname><given-names>G</given-names></name><name><surname>Birlouez-Aragon</surname><given-names>I</given-names></name><name><surname>Silva</surname><given-names>E</given-names></name><name><surname>Friguet</surname><given-names>B</given-names></name></person-group><article-title>Age-dependent protein modifications and declining proteasome activity in the human lens.</article-title><source>Arch Biochem Biophys</source><year>2004</year><volume>427</volume><fpage>197</fpage><lpage>203</lpage><pub-id pub-id-type="pmid">15196994</pub-id></citation></ref><ref id="r27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zetterberg</surname><given-names>M</given-names></name><name><surname>Petersen</surname><given-names>A</given-names></name><name><surname>Sjostrand</surname><given-names>J</given-names></name><name><surname>Karlsson</surname><given-names>J</given-names></name></person-group><article-title>Proteasome activity in human lens nuclei and correlation with age, gender and severity of cataract.</article-title><source>Curr Eye Res</source><year>2003</year><volume>27</volume><fpage>45</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">12868008</pub-id></citation></ref><ref id="r28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grune</surname><given-names>T</given-names></name><name><surname>Merker</surname><given-names>K</given-names></name><name><surname>Sandig</surname><given-names>G</given-names></name><name><surname>Davies</surname><given-names>KJ</given-names></name></person-group><article-title>Selective degradation of oxidatively modified protein substrates by the proteasome.</article-title><source>Biochem Biophys Res Commun</source><year>2003</year><volume>305</volume><fpage>709</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">12763051</pub-id></citation></ref><ref id="r29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>KJ</given-names></name></person-group><article-title>Degradation of oxidized proteins by the 20S proteasome.</article-title><source>Biochimie</source><year>2001</year><volume>83</volume><fpage>301</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">11295490</pub-id></citation></ref><ref id="r30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Horwitz</surname><given-names>J</given-names></name><name><surname>Hansen</surname><given-names>JS</given-names></name><name><surname>Cheung</surname><given-names>CC</given-names></name><name><surname>Ding</surname><given-names>LL</given-names></name><name><surname>Straatsma</surname><given-names>BR</given-names></name><name><surname>Lightfoot</surname><given-names>DO</given-names></name><name><surname>Takemoto</surname><given-names>LJ</given-names></name></person-group><article-title>Presence of low molecular weight polypeptides in human brunescent cataracts.</article-title><source>Biochem Biophys Res Commun</source><year>1983</year><volume>113</volume><fpage>65</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">6860343</pub-id></citation></ref><ref id="r31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>OP</given-names></name><name><surname>Srivastava</surname><given-names>K</given-names></name><name><surname>Silney</surname><given-names>C</given-names></name></person-group><article-title>Levels of crystallin fragments and identification of their origin in water soluble high molecular weight (HMW) proteins of human lenses.</article-title><source>Curr Eye Res</source><year>1996</year><volume>15</volume><fpage>511</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">8670752</pub-id></citation></ref><ref id="r32"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hanson</surname><given-names>SR</given-names></name><name><surname>Hasan</surname><given-names>A</given-names></name><name><surname>Smith</surname><given-names>DL</given-names></name><name><surname>Smith</surname><given-names>JB</given-names></name></person-group><article-title>The major in vivo modifications of the human water-insoluble lens crystallins are disulfide bonds, deamidation, methionine oxidation and backbone cleavage.</article-title><source>Exp Eye Res</source><year>2000</year><volume>71</volume><fpage>195</fpage><lpage>207</lpage><pub-id pub-id-type="pmid">10930324</pub-id></citation></ref><ref id="r33"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Senthilkumar</surname><given-names>R</given-names></name><name><surname>Chaerkady</surname><given-names>R</given-names></name><name><surname>Sharma</surname><given-names>KK</given-names></name></person-group><article-title>Identification and properties of anti-chaperone-like peptides derived from oxidized bovine lens betaL-crystallins.</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>39136</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">12176982</pub-id></citation></ref><ref id="r34"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Udupa</surname><given-names>PE</given-names></name><name><surname>Sharma</surname><given-names>KK</given-names></name></person-group><article-title>Effect of oxidized betaB3-crystallin peptide (152&#x02013;166) on thermal aggregation of bovine lens gamma-crystallins: identification of peptide interacting sites.</article-title><source>Exp Eye Res</source><year>2005</year><volume>80</volume><fpage>185</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">15670797</pub-id></citation></ref><ref id="r35"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Udupa</surname><given-names>EG</given-names></name><name><surname>Sharma</surname><given-names>KK</given-names></name></person-group><article-title>Effect of oxidized betaB3-crystallin peptide on lens betaL-crystallin: interaction with betaB2-crystallin.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2005</year><volume>46</volume><fpage>2514</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">15980243</pub-id></citation></ref><ref id="r36"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Santhoshkumar</surname><given-names>P</given-names></name><name><surname>Udupa</surname><given-names>P</given-names></name><name><surname>Murugesan</surname><given-names>R</given-names></name><name><surname>Sharma</surname><given-names>KK</given-names></name></person-group><article-title>Significance of interactions of low molecular weight crystallin fragments in lens aging and cataract formation.</article-title><source>J Biol Chem</source><year>2008</year>283:8477-85<pub-id pub-id-type="pmid">18227073</pub-id></citation></ref><ref id="r37"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Santhoshkumar</surname><given-names>P</given-names></name><name><surname>Sharma</surname><given-names>KK</given-names></name></person-group><article-title>Identification of a region in alcohol dehydrogenase that binds to alpha-crystallin during chaperone action.</article-title><source>Biochim Biophys Acta</source><year>2002</year><volume>1598</volume><fpage>115</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">12147351</pub-id></citation></ref><ref id="r38"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Horwitz</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>QL</given-names></name><name><surname>Ding</surname><given-names>L</given-names></name><name><surname>Bova</surname><given-names>MP</given-names></name></person-group><article-title>Lens alpha-crystallin: chaperone-like properties.</article-title><source>Methods Enzymol</source><year>1998</year><volume>290</volume><fpage>365</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">9534176</pub-id></citation></ref><ref id="r39"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Santhoshkumar</surname><given-names>P</given-names></name><name><surname>Sharma</surname><given-names>KK</given-names></name></person-group><article-title>Conserved F84 and P86 residues in alphaB-crystallin are essential to effectively prevent the aggregation of substrate proteins.</article-title><source>Protein Sci</source><year>2006</year><volume>15</volume><fpage>2488</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">17075130</pub-id></citation></ref><ref id="r40"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>D</given-names></name><name><surname>Spector</surname><given-names>A</given-names></name></person-group><article-title>Human insoluble lens protein. II. Isolation and characterization of a 9600 dalton polypeptide.</article-title><source>Exp Eye Res</source><year>1978</year><volume>26</volume><fpage>445</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">639891</pub-id></citation></ref><ref id="r41"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharyya</surname><given-names>J</given-names></name><name><surname>Padmanabha Udupa</surname><given-names>EG</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Sharma</surname><given-names>KK</given-names></name></person-group><article-title>Mini-alphaB-crystallin: a functional element of alphaB-crystallin with chaperone-like activity.</article-title><source>Biochemistry</source><year>2006</year><volume>45</volume><fpage>3069</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">16503662</pub-id></citation></ref><ref id="r42"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bova</surname><given-names>MP</given-names></name><name><surname>Yaron</surname><given-names>O</given-names></name><name><surname>Huang</surname><given-names>Q</given-names></name><name><surname>Ding</surname><given-names>L</given-names></name><name><surname>Haley</surname><given-names>DA</given-names></name><name><surname>Stewart</surname><given-names>PL</given-names></name><name><surname>Horwitz</surname><given-names>J</given-names></name></person-group><article-title>Mutation R120G in alphaB-crystallin, which is linked to a desmin-related myopathy, results in an irregular structure and defective chaperone-like function.</article-title><source>Proc Natl Acad Sci USA</source><year>1999</year><volume>96</volume><fpage>6137</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">10339554</pub-id></citation></ref><ref id="r43"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>JG</given-names></name><name><surname>Houck</surname><given-names>SA</given-names></name><name><surname>Clark</surname><given-names>JI</given-names></name></person-group><article-title>Interactive sequences in the molecular chaperone, human alphaB crystallin modulate the fibrillation of amyloidogenic proteins.</article-title><source>Int J Biochem Cell Biol</source><year>2007</year><volume>40</volume><fpage>954</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">18162431</pub-id></citation></ref><ref id="r44"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Plater</surname><given-names>ML</given-names></name><name><surname>Goode</surname><given-names>D</given-names></name><name><surname>Crabbe</surname><given-names>MJ</given-names></name></person-group><article-title>Effects of site-directed mutations on the chaperone-like activity of alphaB-crystallin.</article-title><source>J Biol Chem</source><year>1996</year><volume>271</volume><fpage>28558</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">8910485</pub-id></citation></ref><ref id="r45"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carver</surname><given-names>JA</given-names></name><name><surname>Lindner</surname><given-names>RA</given-names></name></person-group><article-title>NMR spectroscopy of alpha-crystallin. Insights into the structure, interactions and chaperone action of small heat-shock proteins.</article-title><source>Int J Biol Macromol</source><year>1998</year><volume>22</volume><fpage>197</fpage><lpage>209</lpage><pub-id pub-id-type="pmid">9650074</pub-id></citation></ref><ref id="r46"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takeuchi</surname><given-names>N</given-names></name><name><surname>Ouchida</surname><given-names>A</given-names></name><name><surname>Kamei</surname><given-names>A</given-names></name></person-group><article-title>C-terminal truncation of alpha-crystallin in hereditary cataractous rat lens.</article-title><source>Biol Pharm Bull</source><year>2004</year><volume>27</volume><fpage>308</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">14993793</pub-id></citation></ref><ref id="r47"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>JG</given-names></name><name><surname>Estrada</surname><given-names>MR</given-names></name><name><surname>Clark</surname><given-names>JI</given-names></name></person-group><article-title>Interactive domains for chaperone activity in the small heat shock protein, human alphaB crystallin.</article-title><source>Biochemistry</source><year>2005</year><volume>44</volume><fpage>14854</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">16274233</pub-id></citation></ref><ref id="r48"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>JG</given-names></name><name><surname>Shenoy</surname><given-names>AK</given-names><suffix>Jr</suffix></name><name><surname>Clark</surname><given-names>JI</given-names></name></person-group><article-title>N- and C-Terminal motifs in human alphaB crystallin play an important role in the recognition, selection, and solubilization of substrates.</article-title><source>Biochemistry</source><year>2006</year><volume>45</volume><fpage>13847</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">17105203</pub-id></citation></ref><ref id="r49"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>JG</given-names></name><name><surname>Clark</surname><given-names>JI</given-names></name></person-group><article-title>Insights into the domains required for dimerization and assembly of human alphaB crystallin.</article-title><source>Protein Sci</source><year>2005</year><volume>14</volume><fpage>684</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">15722445</pub-id></citation></ref></ref-list></back></article> 